From dumb and dumber investment decisions made to dramatic “You Can’t Handle the Truth” shout-outs roared by actor-wanna-be (Jack Nicholson’s) Colonel Nathan R Jessep-types (“A Few Good Men”), 2011 was a bad…
David J. Phillips Chico’s FAS (NYSE: CHS) said its growth story remains intact, even though consumer spending is expected to remain soft. Additionally, despite falling margins at its flagship stores and rising inventories, the women’s…
Though near-term growth visibility for its cancer vaccine Provenge remains cloudy, Seattle-based Dendreon (DNDN) could be an attractive takeover candidate – especially to a major pharmaceutical house seeking a unique oncology platform.…
David J. Phillips